UBS cuts Qiagen price target, keeps rating neutral
UBS cut its Qiagen price target to $47.00 per share from $52.00 while maintaining a neutral rating, according to TradingView News.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.